Things proceed. In their own time. This ought
Post# of 36537
This ought to be Day 4 of the Peptide Sweepstakes. Which Peptide Ponies will cross the finish line, if any?
I agree with some sentiment expressed here already: aside from the peptide investigation, I believe that the most significant events will be the approval of the S-1 and the Nugenerex spinout...followed shortly by increased funding of Generex operations...breathing life into all of the subsidiaries...and haven’t they hinted that more purchases are in the Works? Whatever happens with a Nugenerex vaccine, andbreally, thebodds are very very long...the real excitement will come from Excellagen , Altucel and Joe making another run at the buccal delivery of insulin.